Vitamin D and Adipose Tissue: a Complex Relationship

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

58 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to verify the role of adipose tissue in determining the vitamin D serum level after monthly oral administration in subjects with vitamin D deficiency.

The main questions it aims to answer are:

* Adipose tissue represents a storage environment for vitamin D or it's an environment where vitamin D is sequestered and no longer released
* On the other hands, it's possible to verify whether the adipose tissue carries out a bi-modal activity towards vitamin D
* If adipose tissue exerts a bi-modal effect, it is possible to identify a specific threshold between the two effects Participants will undergo anthropometric measurements (height, weight, waist/hip ratio waist circumference) at baseline and after 6 months of intake of cholecalciferol 50,000 IU/month

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Duration of Vitamin D Stores After Prolonged Vitamin D Substitution

NCT01729013

Obesity

COMPLETED

Role of Fat Tissue in Vitamin D Metabolism

NCT00033826

Vitamin D Adipose Tissue

COMPLETED

Vitamin D Effects in Overweight Patients

NCT00493012

Overweight Obesity

COMPLETED NA

Vitamin D and Its Metabolites Quantification in Adipose Tissues of Obese and Non-obese Patients.

NCT03008525

Obesity; Endocrine

RECRUITING NA

Effects Of Vitamin D On Bone, Muscle, And Adipose Tissue In Obese Subjects

NCT06508242

Musculoskeletal Diseases Inflammation Sarcopenic Obesity

RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Vitamin D deficiency and insufficiency are prevalent worldwide, and various factors contribute to their occurrence, including low sun exposure, poor dietary intake, obesity, and abdominal obesity. Abdominal obesity, assessed by waist circumference (WC), is associated with metabolic syndrome and has been linked to low vitamin D levels. This study aimed to investigate the relationship between visceral adipose tissue (VAT) and vitamin D levels, particularly examining the potential threshold for vitamin D storage and sequestration by adipose tissue.

The study is conducted on patients with hypovitaminosis D in an internal medicine outpatient department. Blood samples for the evaluation of calcium and vitamin D levels are collected at baseline and after six months of monthly cholecalciferol supplementation. Ultrasonography are used to evaluate adipose tissue measurements, including subcutaneous adipose tissue thickness, VAT, preperitoneal adipose tissue (PPAT), and prerenal adipose tissue (PRAT). Anthropometric measures such as waist-to-hip ratio and waist-to-height ratio are also assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypovitaminosis D

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Vitamin D level \< 20 ng/ml
* BMI \> 24

Exclusion Criteria

* Administration of vitamin D metabolites in the last year
* Previous diagnosis of metabolic bone diseases
* Previous diagnosis of endocrine diseases
* Previous diagnosis of cancer

Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No